BD

Bhagyalaxmi Devaraj Patil

Active Director Director DIN 05121239
DIN 05121239 First appointment Nov 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Nov 2011
Shareholding value •••• Premium profile

About Bhagyalaxmi Devaraj Patil

Data last updated:

Bhagyalaxmi Devaraj Patil is a Director at Bagalkot Health Care Solutions Private Limited (since 2015), Director at Dhanush Arogyasri Private Limited (since 2011) and Director at Dhritidhanu Sugars Private Limited (since 2015). The companies operate in Healthcare and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹12.30 Cr; the largest is Bagalkot Health Care Solutions Private Limited at ₹7.79 Cr (FY 2024). Earlier, Bhagyalaxmi Devaraj Patil was a Director at Dhananjay Cements Private Limited (from 2015).

DIN 05121239
Primary Designation Director
Industry Healthcare
First Appointment 15 Nov 2011
Oldest Company Age 19 yrs
Largest company Bagalkot Health Care Solutions Private Limited · ₹7.79 Cr (FY 2024)
Combined revenue ₹12.30 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Feb 20152015₹7.79 Cr (FY 2024)Active
Dhanush Arogyasri Private Limited U55201KA2006PTC040945
Director15 Nov 20112006₹4.51 Cr (FY 2025)Active
Dhritidhanu Sugars Private Limited U74900KA2015PTC082431
Director21 Aug 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dhananjay Cements Private Limited U26940KA2015PTC082725
Director07 Sep 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dhananjay Cements Private Limited
Dhanush Arogyasri Private Limited
Bagalkot Health Care Solutions Private Limited
Dhritidhanu Sugars Private Limited
Premium access

Shareholding and investment profile for Bhagyalaxmi Devaraj Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhagyalaxmi Devaraj Patil

Bhagyalaxmi Devaraj Patil currently holds 3 directorships: Bagalkot Health Care Solutions Private Limited (Director, since 11 Feb 2015, revenue ₹7.79 Cr (FY 2024)); Dhanush Arogyasri Private Limited (Director, since 15 Nov 2011, revenue ₹4.51 Cr (FY 2025)); Dhritidhanu Sugars Private Limited (Director, since 21 Aug 2015).

Bhagyalaxmi Devaraj Patil was first appointed on 15 Nov 2011 as Director at Dhanush Arogyasri Private Limited. The most recent appointment on record is 07 Sep 2015 at Dhananjay Cements Private Limited.

The 2 current companies of Bhagyalaxmi Devaraj Patil that report revenue have a combined latest revenue of ₹12.30 Cr: Bagalkot Health Care Solutions Private Limited ₹7.79 Cr (FY 2024); Dhanush Arogyasri Private Limited ₹4.51 Cr (FY 2025).

Bhagyalaxmi Devaraj Patil held 1 earlier board appointment: Dhananjay Cements Private Limited (Director, from 07 Sep 2015).

The current boards of Bhagyalaxmi Devaraj Patil's companies include Devaraj Hanamagowda Patil (Bagalkot Health Care Solutions Private Limited), Girish Bhimappa Sangam (Bagalkot Health Care Solutions Private Limited), Girish Vasanad Hanamappa (Bagalkot Health Care Solutions Private Limited), Mahantesh Kalakayya Math (Bagalkot Health Care Solutions Private Limited), Mariyappa Basavantappa Mulimani (Bagalkot Health Care Solutions Private Limited), Raghavendra Narayan Vanaki (Bagalkot Health Care Solutions Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available